Trial Profile
clinical survery for drug adherence and satisfaction of rivaroxaban in non-valvelar patients with atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jun 2019
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Embolism and thrombosis
- Focus Therapeutic Use
- 17 Jun 2019 Status changed from recruiting to completed.
- 15 Jun 2017 New trial record